{"disease":{"id":"non-24-hour-sleep-wake-disorder","name":"non 24 hour sleep wake disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01218789","title":"Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":false},{"nct_id":"NCT02776215","title":"Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":false},{"nct_id":"NCT03956745","title":"Biomarkers for Circadian Timing in Healthy Adults","phase":"","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03980340","title":"Breath Biomarkers for Sleep Loss and Circadian Timing","phase":"","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}